
198.63 Delayed Data As of May 20 | ![]() Today’s Change | 181.00 Today|||52-Week Range 324.81 | -25.35% Year-to-Date |
Insulet (PODD) Q1 Earnings Surpass Estimates, Margins Grow May 09 / Zacks.com - Paid Partner Content |
Previous close | 194.74 |
Today’s open | 198.75 |
Day’s range | 191.77 - 199.99 |
Volume | 344,403 |
Average volume (3 months) | 617,420 |
Market cap | $13.8B |
Earnings growth (last year) | +136.38% |
Earnings growth (this year) | +442.32% |
Earnings growth (next 5 years) | +73.00% |
Revenue growth (last year) | +21.49% |
P/E ratio | 310.4 |
Price/Sales | 16.61 |
Price/Book | 24.72 |
Today’s change | Today’s % change | |
---|---|---|
TFXTeleflex Inc | -0.31 | -0.11% |
ABMDABIOMED Inc | -2.90 | -1.22% |
SAUHFStraumann Holding AG | -3.90 | -3.26% |
---- |
Next reporting date | August 4, 2022 |
EPS forecast (this quarter) | $0.22 |
Annual revenue (last year) | $1.1B |
Annual profit (last year) | $16.8M |
Net profit margin | 1.53% |
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Acton, Massachusetts |